Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
India · Delayed Price · Currency is INR 1,648.00
-1.80 (-0.11%)
May 11, 2026, 3:30 PM IST
Dr. Lal PathLabs Market Cap
Dr. Lal PathLabs has a market cap or net worth of 275.69 billion as of May 11, 2026. Its market cap has increased by 21.90% in one year.
Market Cap
275.69B
Enterprise Value
264.69B
Revenue
27.63B
Ranking
n/a
PE Ratio
54.63
Stock Price
1,648.00
Market Cap Chart
Since December 23, 2015, Dr. Lal PathLabs's market cap has increased from 68.18B to 275.69B, an increase of 304.35%. That is a compound annual growth rate of 14.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 275.69B | 11.28% |
| Dec 31, 2025 | 247.75B | -0.90% |
| Dec 31, 2024 | 250.00B | 16.78% |
| Dec 29, 2023 | 214.08B | 14.42% |
| Dec 30, 2022 | 187.09B | -40.76% |
| Dec 31, 2021 | 315.81B | 66.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.43T |
| Divi's Laboratories | 1.78T |
| Apollo Hospitals Enterprise | 1.16T |
| Cipla | 1.09T |
| Gland Pharma | 313.76B |
| Emcure Pharmaceuticals | 311.50B |
| Inventurus Knowledge Solutions | 291.12B |
| Krishna Institute of Medical Sciences | 287.14B |